tradingkey.logo

Leap Therapeutics Inc <LPTX.OQ> expected to post a loss of 38 cents a share - Earnings Preview

ReutersMay 9, 2025 3:28 PM
  • Leap Therapeutics Inc LPTX.OQ LPTX.O is expected to show no change in quarterly revenue when it reports results on May 12 (estimated) for the period ending March 31 2025

  • ​LSEG's mean analyst estimate for Leap Therapeutics Inc is for a loss of 38 cents per share.

  • The one available analyst rating on the shares is "hold".

  • The mean earnings estimate of analysts had risen by about 6.1% in the last three months. ​

This summary was machine generated May 9 at 15:28 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI